These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 6782642)

  • 1. The effect of irradiated Trypanosoma cruzi on the pathogenesis of Chagas' disease in dogs.
    Tomlinson MJ; Chapman WL; Hanson WL; Goven AJ
    Rev Inst Med Trop Sao Paulo; 1980; 22(5):219-30. PubMed ID: 6782642
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro cellular immunity in Chagas' disease.
    Toledo Barros MA; Amato Neto V; Mendes E; Mota I
    Clin Exp Immunol; 1979 Nov; 38(2):376-80. PubMed ID: 118840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunology of experimental Chagas' disease. II. Delayed hypersensitivity to Trypanosoma cruzi antigens.
    Teixeira AR; Santos-Buch CA
    Immunology; 1975 Mar; 28(3):401-10. PubMed ID: 805088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pregnancy and Trypanosoma cruzi parasitism].
    Storni P; Bolsi FL
    Medicina (B Aires); 1979; 39(2):193-7. PubMed ID: 116106
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of the cellular immune response in Chagas' disease patients.
    Castes M; Araujo Z; Mosca W
    Acta Cient Venez; 1986; 37(5):547-53. PubMed ID: 3129894
    [No Abstract]   [Full Text] [Related]  

  • 6. [Resistance to re-infection by Trypanosoma cruzi in Chagasic mice].
    Basombrió MA
    Medicina (B Aires); 1981; 41 Suppl():230-2. PubMed ID: 6808286
    [No Abstract]   [Full Text] [Related]  

  • 7. Overexpression of neural cell adhesion molecule in Chagas' myocarditis.
    Soler AP; Gilliard G; Xiong Y; Knudsen KA; Martin JL; De Suarez CB; Mota Gamboa JD; Mosca W; Zoppi LB
    Hum Pathol; 2001 Feb; 32(2):149-55. PubMed ID: 11230701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Behavior of blood-stream trypomastigotes of substrains of Trypanosoma cruzi intravenously inoculated in normal and immune mice].
    Ribeiro RD; Belda Neto FM; Ferriolli Filho F
    Rev Bras Biol; 1982 Feb; 42(1):79-83. PubMed ID: 6813919
    [No Abstract]   [Full Text] [Related]  

  • 9. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
    Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
    Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate and acquired immunity in the pathogenesis of Chagas disease.
    Golgher D; Gazzinelli RT
    Autoimmunity; 2004 Aug; 37(5):399-409. PubMed ID: 15621564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Chagas disease in the mouse: III. Absence of concomitant immunity after repeated infections.
    Cabeza Meckert P; Laguens RP
    Medicina (B Aires); 1981; 41(5):543-8. PubMed ID: 6808284
    [No Abstract]   [Full Text] [Related]  

  • 12. [Non-virulence in mice of PF branch of Trypanosoma cruzi. Evaluation through xenodiagnosis, tissue culture and histopathology].
    Menezes H
    AMB Rev Assoc Med Bras; 1976 Apr; 22(4):111-4. PubMed ID: 829996
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental Chagas' disease in dogs. A pathologic and ECG study of the chronic indeterminate phase of the infection.
    Andrade ZA; Andrade SG; Sadigursky M; Maguire JH
    Arch Pathol Lab Med; 1981 Sep; 105(9):460-4. PubMed ID: 6791609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complement system and the inflammatory response in experimental Chagas' disease.
    Irulegui I; Yamashiro EH; Castilho EA; de Brito T
    Rev Inst Med Trop Sao Paulo; 1982; 24(6):349-52. PubMed ID: 6820705
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of the cellular immune response in patients with the digestive and indeterminate forms of Chagas' disease.
    Ribeiro BM; Crema E; Rodrigues V
    Hum Immunol; 2008 Aug; 69(8):484-9. PubMed ID: 18582517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCG-induced resistance in Trypanosoma cruzi experimental infections.
    Bertelli MS; Alcantara A; Brener Z
    Tropenmed Parasitol; 1981 Jun; 32(2):93-6. PubMed ID: 6789512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential impact of metacyclic and blood trypomastigotes on parasitological, serological and phenotypic features triggered during acute Trypanosoma cruzi infection in dogs.
    Carneiro CM; Martins-Filho OA; Reis AB; Veloso VM; Araújo FM; Bahia MT; de Lana M; Machado-Coelho GL; Gazzinelli G; Correa-Oliveira R; Tafuri WL
    Acta Trop; 2007 Feb; 101(2):120-9. PubMed ID: 17296162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Where do we stand on the autoimmunity hypothesis of Chagas disease?
    Kierszenbaum F
    Trends Parasitol; 2005 Nov; 21(11):513-6. PubMed ID: 16125464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection by the Sylvio X10/4 clone of Trypanosoma cruzi: relevance of a low-virulence model of Chagas' disease.
    Marinho CR; Nuñez-Apaza LN; Bortoluci KR; Bombeiro AL; Bucci DZ; Grisotto MG; Sardinha LR; Jorquera CE; Lira S; Lima MR; Alvarez JM
    Microbes Infect; 2009 Nov; 11(13):1037-45. PubMed ID: 19660570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic control of the mechanisms of resistance against experimental Trypanosoma cruzi infection. I: Role of the macrophages in resistant and suceptible strains of mice.
    Pécora IL; Barcinski MA
    Rev Bras Biol; 1979 May; 39(2):445-50. PubMed ID: 119283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.